Daniel Brims
Stock Analyst at Lake Street
(0.05)
# 4,652
Out of 4,670 analysts
23
Total ratings
25.9%
Success rate
-31.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Brims
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KURA Kura Oncology | Reiterated: Buy | $23 | $11.71 | +96.41% | 4 | Aug 13, 2026 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $45 | $6.44 | +598.76% | 3 | Aug 7, 2026 | |
| VKTX Viking Therapeutics | Initiated Coverage: Buy | $89 | $34.36 | +159.02% | 1 | May 28, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $9 | $0.851 | +957.58% | 1 | May 18, 2026 | |
| LITS Lite Strategy | Reiterated: Buy | $7 | $0.9434 | n/a | 7 | Sep 2, 2015 | |
| IMNN Imunon | Maintained: Buy | $7 | $1.58 | n/a | 6 | Aug 10, 2015 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Buy | n/a | $9.41 | n/a | 1 | Dec 30, 2014 |
Kura Oncology
Aug 13, 2026
Reiterated: Buy
Price Target: $23
Current: $11.71
Upside: +96.41%
Aligos Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $6.44
Upside: +598.76%
Viking Therapeutics
May 28, 2026
Initiated Coverage: Buy
Price Target: $89
Current: $34.36
Upside: +159.02%
Rani Therapeutics Holdings
May 18, 2026
Reiterated: Buy
Price Target: $9
Current: $0.851
Upside: +957.58%
Lite Strategy
Sep 2, 2015
Reiterated: Buy
Price Target: $7
Current: $0.9434
Upside: n/a
Imunon
Aug 10, 2015
Maintained: Buy
Price Target: $7
Current: $1.58
Upside: n/a
Bausch Health Companies Inc.
Dec 30, 2014
Maintained: Buy
Price Target: n/a
Current: $9.41
Upside: n/a